Last reviewed · How we verify
Feces sampling
At a glance
| Generic name | Feces sampling |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal
- Microbiota and the Lung Cancer (NA)
- Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
- Viromes in Infants Presenting With a Septic Syndrome (NA)
- Immune Biomarker Study for Salivary Gland Carcinoma
- Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas (NA)
- Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Feces sampling CI brief — competitive landscape report
- Feces sampling updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI